ERGO News 0.7500 Total Nutraceutical (ERGO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Total Nutraceutical (ERGO) 0.7500 $ERGO

Entia: An Iron-Clad Opportunity in a Billion Dollar Market
ACCESSWIRE - Wed Apr 02, 10:31AM CDT
WHITEFISH, MT / April 2, 2014 / Iron is an essential trace metal used throughout the human body. For example, iron is an essential component in a protein called hemoglobin that's responsible for carrying oxygen from the lungs to the rest of the body. Iron deficiency is the most common nutritional deficiency and the leading cause of anaemia in the United States, according to the Centers for Disease Control. Conversely, iron overload can be extremely dangerous and cause issues like liver cirrhosis.

GROH(R) Beauty Line Wins Two Readers' Choice Awards
Marketwire - Thu Feb 13, 2:15PM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) has been notified that its GROH(R) Ergo Boost All-natural Hair and scalp conditioning treatment has received Readers' Choice awards in both the women's and men's hair care product categories from Beauty Launchpad magazine. The GROH Ergo Boost(R) product line, which addresses hair growth and scalp health with a revolutionary blend of Vitamin D infused argan oil and the powerful natural antioxidant L-Ergothioneine, has been selected best new "Women's Thinning Regimen" and "Men's Thinning Treatment" for 2013.

GROH(R) Reaches Important Milestone With Strategic Partner Mario Tricoci Salon Group
Marketwire - Thu Jan 23, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) and its wholly owned subsidiary Total Nutraceutical Solutions (TNS) today announced that the Mario Tricoci Group of salons and day spas, a leading member of the Elizabeth Arden Red Door salon and spa network, will officially launch the entire GROH(R) Ergo Boost product and professional services line on February 1st, 2014. This important milestone and strategic partnership follows an eight month evaluation of the GROH(R) PRO hair and scalp treatment, a deep conditioning back-bar therapy, currently being performed to more than 400 guests per week at Tricoci's seventeen locations. The launch of the full GROH(R) line is further validation of the market interest in the GROH(R) brand and Entia's commercialization strategy for its biotechnology and patent portfolio.

PubNub and Ford AppLink Showcase the Power of the "Internet of Things" with Real-Time Vehicle Dispatch App
PR Newswire - Tue Jan 07, 7:30PM CST
CES - PubNub, the only global Real-Time Network, today announced it is showcasing its winning makeathon integration with the Ford AppLink platform at Ford's booth at CES (North Hall #2222). PubNub was selected as a winner of the VentureBeat and Ford Motor Co. Makeathon for building a real-time dispatch app on PubNub and Ford AppLink. The app provides real-time location tracking and notification via mobile phone to a car's dashboard, bringing Internet of Things communication and technology to cars.

Entia Biosciences' ErgoD2(TM) Could Effectively Treat Parkinson's Disease
ACCESSWIRE - Thu Sep 12, 10:56AM CDT
Entia Biosciences Inc. (OTC Markets: ERGO), a biotechnology company focused on the clinical effects of oxidative stress and free radical reactions in food sciences, has developed a unique compound that combines the power of vitamin D2 with that of ergothioneine. The combination could provide a clinically meaningful response in Parkinson's Disease and a number of other conditions, potentially making the nutritional supplement developer a very lucrative investment.

Entia Biosciences Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
ACCESSWIRE - Tue Sep 03, 1:35PM CDT
SHERWOOD, OR, September 3, 2013 - (ACCESSWIRE) - Entia Biosciences (OTCQB: ERGO), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.

Entia Biosciences: Unlocking the Full Potential of Ergothioneine
ACCESSWIRE - Thu Aug 29, 9:30AM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).

Entia Biosciences (ERGO) Cornering the Market on Ergothioneine
ACCESSWIRE - Wed Aug 28, 12:02PM CDT
Ergothioneine is a naturally occurring amino acid with antioxidant properties. It is commonly found in liver, kidney, black beans, kidney beans and oat bran, as well as bolete and oyster mushrooms. In the late-1920's, human blood testing conducted by researchers (Salt, 1939) showed "normal" ergothioneine levels that were nearly double more recent 2010 results found in a study conducted by Pennsylvania State University (Weigand-Heller, 2012).

Entia Biosciences Completes Parkinson's Disease Study
ACCESSWIRE - Mon Aug 26, 10:50AM CDT
SHERWOOD, OR, August 26, 2013 -(ACCESSWIRE)- Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has completed a Parkinson's disease study in the Neurochemistry Laboratory of Dr. Jack Rogers at Massachusetts General Hospital, Charlestown, MA. The results from the study have been submitted to a peer-reviewed medical journal and the paper is entitled: "Improved Grip Strength and Alpha-Synuclein Levels in a Parkinson's disease Mouse Model Using the Novel Antioxidant Medical Food ErgoD2."

Entia Files PCT Patent on Athletic Performance
ACCESSWIRE - Wed Jul 03, 9:05AM CDT
Sherwood, OR, July 3, 2013 - (eTeligis via Accesswire) - Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, announced today that it has filed a PCT patent covering the use of Ergothioneine (Ergo) and/or Vitamin D2 (Ergocalciferol) to physiologically support and improve athletic performance (strength, endurance, balance, and conditioning), prevent and repair injuries, improve muscular dysfunction in diseases (Parkinson's disease, multiple sclerosis), and maintain normal muscle cellular health by increasing the oxygen carrying capacity of blood. This invention also relates to the use of these powerful antioxidants in pharmaceutical, nutraceutical, functional ingredients, and medical food compositions to increase blood iron levels, percentage iron saturation, and production of important bioactive molecules, including but not limited to glutathione, alpha synuclein, and IL6. Extraction of Ergo and Vitamin D2 from whole food sou

Entia's Organic Vitamin D Enrichment Process Receives US Patent
ACCESSWIRE - Mon Jun 17, 2:33PM CDT
Penn State Research Foundation Expands Company's Exclusive License

Entia hires director of marketing for medical foods and consumer products
PR Newswire - Wed May 15, 1:08PM CDT
Entia Biosciences, Inc. (OTCQB: ERGO) announced today it has hired Sabrina Jetton to spearhead the Company's product innovation, communications, and branding initiatives as Director of Marketing. Since joining the team in April, Jetton has been leading the preparations for the upcoming launch of the expanded GROH® hair care and beauty line, which will be introduced May 19-20 during the Spring Symposium of Intercoiffure in Hollywood, Florida.

Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
PR Newswire - Tue Apr 02, 11:10AM CDT
Entia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of Nutrigenomics, has now received three Patent Notices of Allowance covering the use of Ergothioneine and its genetic transporter in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Notices from the United States Patent and Trademark Office and the Israel Patent Office were received in March and from the Canadian Intellectual Property Office in December.

Entia Biosciences Receives Expanded USDA Organic Certification
PR Newswire - Thu Feb 28, 9:00AM CST
Entia Biosciences, Inc. (OTCQB: ERGO) (ENTIA) announced today that its USDA organic certification for manufacturing and handling has been expanded to include the extraction and processing of two new mushroom-based ingredients developed by Entia and its academic research partners. Ergo Essence(TM) and Chitin-Glucan Complex(TM) are functional ingredients extracted from the whole food that contain naturally high concentrations of L-Ergothioneine (Ergo), Ergocalciferol (vitamin D2), and other important nutrients that Entia research has shown play an important role in cell health and rejuvenation. Entia expects to begin incorporating these new "100% USDA Organic" ingredients into its expanded GROH® hair care and cosmetics line which will be introduced to the beauty industry later this year.

Entia Receives Canadian Patent Notice of Allowance for Use of Ergothioneine and its Genetic Transporter
PR Newswire - Mon Dec 17, 9:00AM CST
Entia Biosciences (OTCBB: ERGO), a food science biotechnology company and emerging leader in the fields of Nutrigenomics and Targeted Nutrition, has received a Patent Notice of Allowance from the Canadian Intellectual Property Office covering the use of Ergothioneine and its genetic transporter (SLC22A4) in the treatment of a wide variety of diseases, including those affecting the immune and central nervous systems. Ergothioneine is a powerful amino acid and master antioxidant that is acquired exclusively from the diet and carried by this unique and specific transporter to cells throughout the body that are fighting damage and death from oxidative stress and toxic free radical reactions. Research conducted by Entia since 2011 has confirmed significant transporter activity in diabetes, arthritis, and several other serious non-communicable chronic conditions, suggesting an important physiologic role for Ergothioneine in diseases affecting millions of people world-wide.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 55

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
Australia Leads TTW's 2027 Global Travel Country List

Updated Category News Views 0

A travel ranking is a map, not a balance sheet, and that distinction matters more than the glossy numbering. TTW has put Australia at the head of its editorial list of the 50 best countries to visit in 2027, followed by Switzerland, Japan, Canada and Thailand. Fair enough. Those are formidable tourism brands with the scenery, infrastructure and cultural pull to back up...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

Colossus SSP Partners with Scope3 for Sustainable Advertising

Updated Category News Views 852

Colossus SSP Teams Up with Scope3 for Green Media Solutions Colossus Media LLC, also known as Colossus SSP, is making strides in the advertising sector by integrating with Scope3, a prominent provider of carbon emissions data. This collaboration empowers Colossus SSP to present superior green media solutions, thereby allowing brands and agencies to show greater commitment...

Continue Reading
SSC Security Services Enhances Structure Through Amalgamation

Updated Category News Views 110

SSC Security Services Corp. Completes Subsidiary Amalgamation SSC Security Services Corp., commonly referred to as SSC, is pleased to announce the successful completion of a horizontal short-form amalgamation of its wholly owned operating subsidiaries, Logixx Security Inc. and SRG Security Resource Group Inc. This strategic move is part of a larger effort to streamline...

Continue Reading
Biden Administration Takes Action to Enhance Airline Competition

Updated Category News Views 64

Biden Administration Takes a Firm Stand on Airline Competition The U.S. government is stepping up efforts to ensure fair competition in the airline industry. The Justice Department's Antitrust Division, along with the Transportation Department, has initiated a comprehensive public inquiry into the landscape of air travel competition. Prioritizing Airline Competition...

Continue Reading
Atlassian Reports Exceptional Growth in Fiscal Performance

Updated Category News Views 101

Atlassian's Strong Fiscal Performance Atlassian Corp Plc (NASDAQ: TEAM) has recently delivered its fiscal first quarter results, much to the delight of analysts and investors alike. The report highlighted impressive growth in both its cloud and data center sectors, which significantly contributed to its revenues, surpassing Wall Street's expectations. Highlights from the...

Continue Reading
Actinium Pharmaceuticals Lawsuit: What Investors Should Know Now

Updated Category News Views 238

Actinium Pharmaceuticals Class Action Lawsuit Overview In recent developments surrounding Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), investors are presented with an opportunity to lead a securities fraud class action lawsuit. This initiative is spearheaded by Rosen Law Firm, a reputable global entity vigorously advocating for investor rights. Key Details for...

Continue Reading